I. Torre-Salaberri
Hospital de Basurto(ES)
Publications by Year
Research Areas
Ocular Diseases and Behçet’s Syndrome, Systemic Lupus Erythematosus Research, Retinal and Optic Conditions, Ophthalmology and Eye Disorders, Otitis Media and Relapsing Polychondritis
Most-Cited Works
- → Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases(2019)106 cited
- → Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients(2020)81 cited
- → Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients(2022)20 cited
- → Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet’s Disease(2024)4 cited
- → AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES' ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE(2019)3 cited
- → FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET'S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES(2019)2 cited
- → SAT0235 BIOLOGICAL THERAPYIN NEUROBEHÇET. MULTICENTER STUDY OF 29 PATIENTS(2019)1 cited
- → THU0311 CERTOLIZUMAB THERAPY IN REFRACTORY UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMID). MULTICENTER STUDY OF 39 PATIENTS(2020)1 cited
- → FRI0504 TOCILIZUMAB IN GRAVES' ORBITOPATHY. MULTICENTER STUDY OF 48 PATIENTS.(2020)1 cited
- → AB0771 HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE INDUCES RAPID IMPROVEMENT OF VISUAL ACUITY IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES(2021)